XML 38 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)
shares in Millions
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Significant Accounting Policies [Line Items]        
Accumulated deficit $ (118,525,572)   $ (110,126,902)  
Cash and cash equivalents 39,316,911 $ 7,660,151 $ 51,674,087 $ 4,669,467
Working capital 31,400,000      
Net loss 8,398,670 $ 7,323,644    
Cash flow from operations $ (12,300,000)      
Period of insufficient cash and liquidity requirements 12 months      
Common stock reserved for future issuance (in shares) 27      
Organon        
Significant Accounting Policies [Line Items]        
Upfront license fee paid $ 10,000,000      
Milestone payment paid in common stock 182,500,000      
First commercial sale amount 2,500,000      
Sales based milestones amount $ 180,000,000